RxSight (RXST) shares were down more than 12% in recent Friday trading after Stifel downgraded the company's stock to hold from buy and cut its price target to $40 from $65.
Trading volume stood at about 1.5 million shares against a daily average of about 580,000 shares.
Price: 33.38, Change: -4.81, Percent Change: -12.59
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。